<unk>  is an acronym for the name of a chemotherapy regimen that is intended for treatment of aggressive non-Hodgkin lymphomas. Unlike CHOP, this chemotherapy regimen does not contain doxorubicin or any other anthracycline. Thus, it can be used in patients with severe cardiovascular diseases and contraindications for doxorubicin-containing regimens. There are 2 modifications of<unk>  - with the addition of bleomycin, called<unk>  (B), and without bleomycin - ordinary<unk> . This regimen also does not contain vincristine and can be used in patients with neuropathy. In combination with anti-CD20, monoclonal, antibody, and rituximab. this regimen is called R-CEPP(B). R-CEPP(B) regimen consists of: # - a monoclonal antibody that is able to kill CD20-positive B cells, either normal or malignant; # (C)yclophosphamide - an alkylating antineoplastic agent; # - a topoisomerase inhibitor from the epipodophyllotoxin group; # - an alkylating antineoplastic agent; # or - a glucocorticoid hormone that has the ability to cause apoptosis and lysis of lymphocytes, either normal or malignant; # - an antitumor antibiotic.
CEPP
CARB-X
CURB-65
MCN
CoWIN
C-KAD
BGR-34
GL-ONC1